This is a downloadable editorial summarising the findings from 17 papers associated with it. All the papers under this title are available separately on the website - I think by pressing the red lined individuals mentioned, you will arrive at the appropriate papers. At least some notice is being taken as to the needs for such therapy in suitable individuals. However, if at the same time, TSH in the reference range is required, the authors are going to be sorely disappointed if they try to juggle suitable FT3 levels with detectable TSH. Dropping TSH down to its primary detection role, as opposed to monitoring therapy, is the required next step, one which they'll find difficult to take.
Front. Endocrinol., 25 June 2020 | doi.org/10.3389/fendo.2020....
Editorial: Combination Therapy for Hypothyroidism: The Journey From Bench to Bedside
Jacqueline Jonklaas1, Anne R. Cappola and Francesco S. Celi